Published in J Autoimmun on April 01, 1990
Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol (1998) 11.07
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (1991) 2.67
Contrast, induction, facilitation, suppression, and conservation. J Exp Anal Behav (1976) 2.50
CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49
Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature (1988) 2.46
Peripheral deletion of self-reactive B cells. Nature (1991) 2.34
Tolerance of class I histocompatibility antigens expressed extrathymically. Nature (1989) 2.19
Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes (1997) 2.19
Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction (1994) 2.11
The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: identification of constant and variable peptides. Cell (1983) 2.04
Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature (1992) 1.92
Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature (1990) 1.87
Too much of a good thing: why it is bad to stimulate the beta cell to secrete insulin. Diabetologia (2008) 1.79
Self-ignorance in the peripheral T-cell pool. Immunol Rev (1993) 1.73
Postoperative cognitive deficit in the elderly surgical patient. Br J Anaesth (1998) 1.72
Induction of autoimmune diabetes by oral administration of autoantigen. Science (1996) 1.69
Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London. Atherosclerosis (1988) 1.58
Visceral adipose tissue and cardiovascular risk factors in obese children. J Pediatr (1998) 1.49
Effect of physical training on total and visceral fat in obese children. Med Sci Sports Exerc (1999) 1.48
Peripheral T cell tolerance. Annu Rev Immunol (1992) 1.47
Paired baseline performance as a behavioral ideal. J Exp Anal Behav (1981) 1.46
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc Natl Acad Sci U S A (1989) 1.44
Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs. Arthritis Rheum (2007) 1.43
The nu gene acts cell-autonomously and is required for differentiation of thymic epithelial progenitors. Proc Natl Acad Sci U S A (1996) 1.43
Clonal deletion of autospecific B lymphocytes. Immunol Rev (1991) 1.42
An idiotypic determinant formed by both immunoglobulin constant and variable regions. Nature (1983) 1.42
The discovery of the immunological function of the thymus. Immunol Today (1991) 1.42
Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol (1995) 1.40
An approach to locate phosphorylation sites in a phosphoprotein: mass mapping by combining specific enzymatic degradation with matrix-assisted laser desorption/ionization mass spectrometry. Anal Biochem (1994) 1.38
Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun (2000) 1.38
RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J Immunol (1996) 1.32
Fat distribution and hemostatic measures in obese children. Am J Clin Nutr (1998) 1.31
Partial nucleotide sequence of human calcitonin precursor mRNA identifies flanking cryptic peptides. Nature (1982) 1.31
Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose? J Virol (1998) 1.28
HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens (2003) 1.28
Enhanced detection of phosphopeptides in matrix-assisted laser desorption/ionization mass spectrometry using ammonium salts. J Am Soc Mass Spectrom (1999) 1.26
Immunological tolerance: new approaches using transgenic mice. Immunol Today (1989) 1.25
The peritoneal Ly-1 (CD5) B cell repertoire is unique among murine B cell repertoires. Eur J Immunol (1990) 1.25
Production of RNA for secreted immunoglobulin mu chains does not require transcriptional termination 5' to the microM exons. Nature (1983) 1.24
Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes. Diabetologia (2007) 1.23
Tolerance induction by thymic medullary epithelium. Proc Natl Acad Sci U S A (1992) 1.21
Conservation, choice, and the concurrent fixed-ratio schedule. J Exp Anal Behav (1978) 1.18
Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype. Genes Immun (2004) 1.18
Antigenic variation in African trypanosomes by gene replacement or activation of alternate telomeres. Cell (1984) 1.17
Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens. Immunol Rev (1998) 1.10
(TAA)n within sequences flanking several intrachromosomal variant surface glycoprotein genes in Trypanosoma brucei. Nucleic Acids Res (1985) 1.10
The construction and partial characterization of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein. Biochem J (1981) 1.07
C57BL/6 and C57BL/10 inbred mouse strains differ at multiple loci on chromosome 4. Immunogenetics (1994) 1.03
A transgenic approach to the study of peripheral T-cell tolerance. Immunol Rev (1991) 1.03
Microbehavioral features of nutritive and nonnutritive drinking in rats. J Comp Physiol Psychol (1971) 1.03
Induction of delayed-type hypersensitivity to azobenzenearsonate by a monoclonal anti-idiotype antibody. J Exp Med (1981) 1.02
Visceral adipose tissue and markers of the insulin resistance syndrome in obese black and white teenagers. Obes Res (2000) 1.02
Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths. Int J Obes Relat Metab Disord (2002) 0.99
The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome. Genes Immun (2009) 0.98
Clinical research nursing: a critical resource in the national research enterprise. Nurs Outlook (2011) 0.98
Prediction of visceral adipose tissue from simple anthropometric measurements in youths with obesity. Obes Res (1999) 0.97
Polymorphisms in the Il12b gene affect structure and expression of IL-12 in NOD and other autoimmune-prone mouse strains. Genes Immun (2002) 0.97
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96
Sclerotherapy of esophageal varices. Arch Surg (1980) 0.95
Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response. J Clin Invest (1995) 0.95
Overview of the Type I Diabetes Genetics Consortium. Genes Immun (2009) 0.95
Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort. J Rheumatol (2001) 0.95
The beta cell in autoimmune diabetes: many mechanisms and pathways of loss. Trends Endocrinol Metab (2001) 0.94
Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers. J Clin Psychopharmacol (1997) 0.94
Confirmation of novel type 1 diabetes risk loci in families. Diabetologia (2012) 0.93
Sexing single larval stages of Schistosoma mansoni by polymerase chain reaction. Mol Biochem Parasitol (1991) 0.91
MHC molecules and beta-cell destruction. Immune and nonimmune mechanisms. Diabetes (1989) 0.90
rs2476601 T allele (R620W) defines high-risk PTPN22 type I diabetes-associated haplotypes with preliminary evidence for an additional protective haplotype. Genes Immun (2009) 0.90
Targeted insertion of a lacZ reporter gene into the mouse Cer1 locus reveals complex and dynamic expression during embryogenesis. Genesis (2000) 0.90
Extrathymic acquisition of tolerance by T lymphocytes. Cold Spring Harb Symp Quant Biol (1989) 0.89
Monozygotic twins discordant for congenital complete heart block. Arthritis Rheum (1997) 0.89
An evaluation of the mutagenicity, metabolism, and DNA adduct formation of 5-nitrobenzo[b]naphtho[2,1-d]thiophene. Chem Res Toxicol (2001) 0.88
Results of the MHC fine mapping workshop. Diabetes Obes Metab (2009) 0.87
Enhanced detection of oligonucleotides in UV MALDI MS using the tetraamine spermine as a matrix additive. Anal Chem (1999) 0.87
Selection of the T-cell repertoire in transgenic mice expressing a transplantation antigen in distinct thymus subsets. Proc Biol Sci (1990) 0.87
Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes. Genes Immun (2009) 0.86
Localization of Idd11 using NOD congenic mouse strains: elimination of Slc9a1 as a candidate gene. Immunogenetics (2000) 0.86
Phorbol 12-myristate 13-acetate-induced phosphorylation of Op18 in Jurkat T cells. Identification of phosphorylation sites by matrix-assisted laser desorption ionization mass spectrometry. J Biol Chem (1993) 0.86
Physician performance improvement: an overview of methodologies. Clin Exp Rheumatol (2007) 0.86
Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes. Diabetologia (1998) 0.85
Expected psychological reactions to disaster in medical rescue teams. Mil Med (1981) 0.84
No association of the IRS1 and PAX4 genes with type I diabetes. Genes Immun (2009) 0.84
Beta-cell apoptosis in an accelerated model of autoimmune diabetes. Mol Med (1998) 0.83
Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet beta-cells. Eur J Immunol (1994) 0.83
Measurement of the CP asymmetry amplitude sin2beta with B0 mesons. Phys Rev Lett (2002) 0.83
Efficiency and persistence of licking in rats. Physiol Behav (1990) 0.83
Observation of the semileptonic decays B-->D*tau-nutau and evidence for B-->Dtau-nutau. Phys Rev Lett (2008) 0.83
Observation of a new Ds meson decaying to DK at a mass of 2.86 GeV/c2. Phys Rev Lett (2006) 0.82
A quantitative comparison of dibenzo[a,l]pyrene-DNA adduct formation by recombinant human cytochrome P450 microsomes. Mol Carcinog (1999) 0.82
T-cell tolerance in transgenic mice expressing major histocompatibility class I molecules in defined tissues. Immunol Rev (1989) 0.82
Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. Am J Pathol (1994) 0.82